Crinetics Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Crinetics Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Crinetics Pharmaceuticals Inc
Rating: 1.02666675
Author: Trendlyne DVM scores

about

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltu...

36.77 -1.54 (-4.02%)

36.59% Fall from 52W High

1.1M

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.7 / 100

Technically Bearish

33.4 / 100

1Yr Price target upside is 126%

14 analysts

Crinetics Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Crinetics Pharma Inc Live Stock Price Today, Share Analysis and Chart

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltu...

36.59% Fall from 52W High

SWOT Analysis

Crinetics Pharma Inc Live Price Chart